ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,043Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 352

$1.55M Total Retail Price of All Prescriptions

Rank: 2 out of 352

760 Patients Receiving at Least One Drug in Part D
94% Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Illinois
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 760 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

15% of this provider’s 760 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $93 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Illinois
WARFARIN SODIUM 1,157 1,118 85 1 12
LEVOTHYROXINE SODIUM 1,056 1,004 163 2 7
NAMENDA 1,040 973 86 3 24
FUROSEMIDE 983 950 150 4 6
OMEPRAZOLE 757 672 132 5 5
DONEPEZIL HCL 655 634 99 6 22
LISINOPRIL 628 591 117 7 3
METOPROLOL TARTRATE 620 592 113 8 11
AMLODIPINE BESYLATE 597 592* 105 9 4
ATORVASTATIN CALCIUM 568 501 109 10 8
SIMVASTATIN 486 481* 91 11 2
QUETIAPINE FUMARATE 408 403* 54 A 12 35
CYMBALTA 392 326 35 13 52
HYDROCODONE-ACETAMINOPHEN 392 339 111 S3 13 1
HYDROCHLOROTHIAZIDE 384 347 69 15 17
ALENDRONATE SODIUM 353 342 48 16 43
POTASSIUM CHLORIDE 331 320 55 17 26
ESCITALOPRAM OXALATE 328 297 51 18 42
GABAPENTIN 286 236 51 19 13
EXELON 278 273* 38 20 119
METOPROLOL SUCCINATE 276 262 58 21 9
MIRTAZAPINE 274 261 44 22 64
METFORMIN HCL 264 246 44 23 15
CLOPIDOGREL 260 224 43 24 14
LORAZEPAM 258 237 57 B 25 32
KLOR-CON M20 249 237 46 26 108
ATENOLOL 249 238 43 26 25
TAMSULOSIN HCL 209 204* 44 28 16
ABILIFY 203 152 17 A 29 74
NAMENDA XR 200 195* 46 30 232
CITALOPRAM HBR 198 183 35 31 47
ALPRAZOLAM 192 146 42 B 32 19
DIVALPROEX SODIUM 192 192 28 32 80
TRAZODONE HCL 191 165 25 34 40
CARBIDOPA-LEVODOPA 180 180 25 35 56
SERTRALINE HCL 177 157 27 36 30
DIOVAN 173 168* 25 37 66
PANTOPRAZOLE SODIUM 169 145 45 38 21
MONTELUKAST SODIUM 165 148 54 39 39
LEVETIRACETAM 163 82 21 40 41
BUMETANIDE 163 163 37 40 149
LIDODERM 160 155* 40 42 148
BACLOFEN 157 87 14 43 121
LOSARTAN POTASSIUM 156 151* 29 44 20
CIPROFLOXACIN HCL 155 138 87 45 60
FINASTERIDE 154 143 25 46 37
FAMOTIDINE* 153 131 28 47 59
OXYBUTYNIN CHLORIDE ER 148 109 21 48 82
POLYETHYLENE GLYCOL 3350 143 127 33 49 90
LANTUS 142 110 27 50 85
PREDNISONE 138 133* 36 51 28
TRAMADOL HCL 136 131* 62 52 27
ALLOPURINOL 136 123 32 52 57
CLONAZEPAM 131 126* 18 B 54 31
PHENYTOIN SODIUM EXTENDED 128 92 16 55 147
IPRATROPIUM-ALBUTEROL 123 99 56 56 154
AMOX TR-POTASSIUM CLAVULANATE 115 110* 69 57 163
CARVEDILOL 112 92 24 58 18
PRAVASTATIN SODIUM 111 111 26 59 29
DIGOX 107 102* 23 60 77
NIASPAN 101 <11 <11 61 230
GLIPIZIDE 101 101 17 61 79
ZOLPIDEM TARTRATE 100 78 27 63 50
BENAZEPRIL HCL 97 92* 13 64 162
SULFAMETHOXAZOLE-TRIMETHOPRIM 96 91* 60 65 133
ADVAIR DISKUS 94 89* 28 66 49
NOVOLOG 93 76 18 67 199
HYDROXYZINE HCL 91 58 11 R 68 251
JANUVIA 90 <11 <11 69 109
FLUTICASONE PROPIONATE 90 64 23 69 34
LOVASTATIN 90 78 12 69 114
LEVOFLOXACIN 87 82* 53 72 128
NYSTATIN-TRIAMCINOLONE 87 82* 18 72 258
TRIAMCINOLONE ACETONIDE 84 79* 30 74 44
HYDRALAZINE HCL 84 84 24 74 85
AMITRIPTYLINE HCL 83 71 11 R 76 93
NYSTOP 78 73* 33 77 308
TEMAZEPAM 77 72* 21 B 78 237
LANTUS SOLOSTAR 76 71* 15 79 95
SANTYL 75 51 24 80 312
OLANZAPINE 75 58 13 A 80 88
SPIRONOLACTONE 73 73 14 82 66
ZEMPLAR 72 72 13 83 269
SPIRIVA 72 72 19 83 54
AMIODARONE HCL 70 70 16 85 115
LAMOTRIGINE 70 <11 <11 85 65
HALOPERIDOL 70 <11 <11 A 85 168
HUMALOG 68 63* 16 88 130
VESICARE 67 <11 <11 89 122
MUPIROCIN* 64 53 29 90 160
DIVALPROEX SODIUM ER 64 <11 <11 90 102
NITROFURANTOIN MONO-MACRO 63 33 22 92 267
BRIMONIDINE TARTRATE 63 <11 <11 92 81
ENOXAPARIN SODIUM 62 57* 20 94 334
NUEDEXTA 62 <11 <11 94 281
ENABLEX 61 <11 <11 96 338
CLOTRIMAZOLE-BETAMETHASONE 61 33 17 96 165
RISPERIDONE 61 61 12 A 96 45
CEPHALEXIN 60 55* 21 99 112
LIDOCAINE 59 54* 33 100 341
DILTIAZEM 24HR CD 59 <11 <11 100 181
PAROXETINE HCL 58 53* 13 102 118
MEGESTROL ACETATE 58 58 15 R 102 343
GLIMEPIRIDE 57 <11 <11 104 76
ONDANSETRON HCL* 56 51* 29 105 189
MELOXICAM 53 <11 <11 106 100
GLIPIZIDE ER 53 53 12 106 243
LYRICA 52 <11 <11 108 75
TRIAMTERENE-HCTZ 52 52 11 108 126
NYSTATIN 51 51 24 110 230
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.